Ucb SA (UCB) NPV (CDI)

Sell:€237.00Buy:€242.70Price decreased€7.30 (2.96%)

Prices delayed by at least 15 minutes
Sell:€237.00
Buy:€242.70
Change:Price decreased€7.30 (2.96%)
Deal now
Prices delayed by at least 15 minutes
Sell:€237.00
Buy:€242.70
Change:Price decreased€7.30 (2.96%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open€244.10
Previous close€246.30
Market cap€47.91bn
P/E ratio30.09
Volume299,812
Dividend yield0.59%
EMS-

Company information

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system ...

  • LocationBelgium
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyEUR
  • Shares in issue194.51m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share€1.39
  • Ex-dividend date25 April 2025
  • Payment date29 April 2025

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.